These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 12217334)
1. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Zangerle R; Widner B; Quirchmair G; Neurauter G; Sarcletti M; Fuchs D Clin Immunol; 2002 Sep; 104(3):242-7. PubMed ID: 12217334 [TBL] [Abstract][Full Text] [Related]
2. Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection. Neurauter G; Zangerle R; Widner B; Quirchmair G; Sarcletti M; Fuchs D Adv Exp Med Biol; 2003; 527():317-23. PubMed ID: 15206745 [TBL] [Abstract][Full Text] [Related]
3. Tryptophan degradation in patients with gynecological cancer correlates with immune activation. Schroecksnadel K; Winkler C; Fuith LC; Fuchs D Cancer Lett; 2005 Jun; 223(2):323-9. PubMed ID: 15896467 [TBL] [Abstract][Full Text] [Related]
4. Tryptophan degradation during and after gestation. Schröcksnadel K; Widner B; Bergant A; Neurauter G; Schröcksnadel H; Fuchs D Adv Exp Med Biol; 2003; 527():77-83. PubMed ID: 15206718 [TBL] [Abstract][Full Text] [Related]
5. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population. Bipath P; Levay PF; Viljoen M BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873 [TBL] [Abstract][Full Text] [Related]
6. The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy. Byakwaga H; Boum Y; Huang Y; Muzoora C; Kembabazi A; Weiser SD; Bennett J; Cao H; Haberer JE; Deeks SG; Bangsberg DR; McCune JM; Martin JN; Hunt PW J Infect Dis; 2014 Aug; 210(3):383-91. PubMed ID: 24585899 [TBL] [Abstract][Full Text] [Related]
7. Neopterin levels and Kyn/Trp ratios were significantly increased in dengue virus patients and subsequently decreased after recovery. Geisler S; Lytton SD; Toan NL; Nghia TH; Nam NM; Hung HV; Son NT; Anh DT; Tuyen HT; Tien TV; Quyet D; Van Tong H; Hoan NX; Song LH; Pallerla SR; Gostner JM; Fuchs D; Velavan TP Int J Infect Dis; 2020 Feb; 91():162-168. PubMed ID: 31821895 [TBL] [Abstract][Full Text] [Related]
8. Influence of immunosuppressive agents on tryptophan degradation and neopterin production in human peripheral blood mononuclear cells. Schroecksnadel S; Sucher R; Kurz K; Fuchs D; Brandacher G Transpl Immunol; 2011 Sep; 25(2-3):119-23. PubMed ID: 21742032 [TBL] [Abstract][Full Text] [Related]
9. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Frick B; Schroecksnadel K; Neurauter G; Leblhuber F; Fuchs D Clin Biochem; 2004 Aug; 37(8):684-7. PubMed ID: 15302611 [TBL] [Abstract][Full Text] [Related]
10. Associations of microbial and indoleamine-2,3-dioxygenase-derived tryptophan metabolites with immune activation in healthy adults. Riazati N; Kable ME; Newman JW; Adkins Y; Freytag T; Jiang X; Stephensen CB Front Immunol; 2022; 13():917966. PubMed ID: 36248784 [TBL] [Abstract][Full Text] [Related]
11. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors. Ploder M; Spittler A; Schroecksnadel K; Neurauter G; Pelinka LE; Roth E; Fuchs D Clin Sci (Lond); 2009 Apr; 116(7):593-8. PubMed ID: 18986303 [TBL] [Abstract][Full Text] [Related]
12. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection. Jenabian MA; El-Far M; Vyboh K; Kema I; Costiniuk CT; Thomas R; Baril JG; LeBlanc R; Kanagaratham C; Radzioch D; Allam O; Ahmad A; Lebouché B; Tremblay C; Ancuta P; Routy JP; J Infect Dis; 2015 Aug; 212(3):355-66. PubMed ID: 25616404 [TBL] [Abstract][Full Text] [Related]
14. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Fuchs D; Möller AA; Reibnegger G; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H Immunol Lett; 1991 Jun; 28(3):207-11. PubMed ID: 1909303 [TBL] [Abstract][Full Text] [Related]
15. Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy. Chen J; Xun J; Yang J; Ji Y; Liu L; Qi T; Wang Z; Zhang R; Shen Y; Ponte R; Mehraj V; Routy JP; Lu H Clin Infect Dis; 2019 Apr; 68(8):1274-1281. PubMed ID: 30107503 [TBL] [Abstract][Full Text] [Related]
17. Tryptophan-kynurenine profile in pediatric autoimmune hepatitis. Lytton SD; Osiecki M; MałgorzataWoźniak ; Cukrowska B; Wierzbicka A; Goliszek M; Socha P; Janczyk W; Dayanakli D; Abendroth D; Kramp S; Fechner K; Scheper T; Mahler M; Bentow C; Bogdanos D; Fuchs D; Woynarowski M Immunol Res; 2019 Feb; 67(1):39-47. PubMed ID: 30666511 [TBL] [Abstract][Full Text] [Related]
18. Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. Schroecksnadel K; Kaser S; Ledochowski M; Neurauter G; Mur E; Herold M; Fuchs D J Rheumatol; 2003 Sep; 30(9):1935-9. PubMed ID: 12966593 [TBL] [Abstract][Full Text] [Related]
19. Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Brown RR; Ozaki Y; Datta SP; Borden EC; Sondel PM; Malone DG Adv Exp Med Biol; 1991; 294():425-35. PubMed ID: 1722946 [TBL] [Abstract][Full Text] [Related]
20. Peripheral kynurenine/tryptophan ratio is not a reliable marker of systemic indoleamine 2,3-dioxygenase: A lesson drawn from patients on hemodialysis. Chen Y; Xie Z; Xiao C; Zhang M; Li Z; Xie J; Zhang Y; Zhao X; Zeng P; Mo L; Liang X; Shi W Oncotarget; 2017 Apr; 8(15):25261-25269. PubMed ID: 28445957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]